Endpoints News 生物医药· Reynald Castaneda·· 9 天前AI 评分40
Merck KGaA 获 FDA 批准其从 Abbisko 许可的肿瘤药物用于罕见非癌性肿瘤
Merck KGaA lands FDA nod for joint tumor drug it licensed from Abbisko
AI 导读
Merck KGaA 获得 FDA 批准,其从中国生物技术公司 Abbisko 许可的药物可用于治疗罕见非癌性肿瘤。
正文
Merck KGaA said Tuesday that the drug it licensed from a China-based biotech has secured FDA approval for rare noncancerous tumors …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news